ESMO-EANM Virtual Advanced Course on Diagnostic and Therapeutic Applications of Nuclear Medicine in Oncology 2021

- Start date
- 16 Jul 2021
- End date
- 17 Jul 2021
- Location
- Virtual, CEST Time
- Application deadline
- 03 May 2021
Please kindly note that the virtual course programme timings are to be considered CEST (Central European Summer Time)
Learning objectives
- To get an updated analysis of the diagnostic and therapeutic applications of nuclear medicine in oncology
- To provide a knowledge of principles of both nuclear medicine modalities and systemic oncologic therapies in end-term trainees and specialists in oncology and nuclear medicine
- To provide an educational framework for in-depth analysis of the combined diagnostic/therapeutic strategies (theranostics) in oncology and scientific interaction between oncology and nuclear medicine experts
Download the preliminary programme
How to apply
Application is via online form. During the application process you will be required to upload the following:
- Your CV including a list of your publications
Application deadline
Application for the virtual course will close on 3 May 2021
Who can apply?
While this course is primarily aimed at experienced oncologists resident in Europe, application is open to all ESMO members.
To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.
What's included?
Successful applicants will benefit from complimentary registration for this virtual course.
Accreditation
The programme of this virtual event will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Paola A. Erba, Italy
- Stefano Fanti, Italy
- Florian Lordick, Germany